References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [updated 2017] Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed January 3, 2017
- AryalSDiaz-GuzmanEManninoDMInfluence of sex on chronic obstructive pulmonary disease risk and treatment outcomesInt J Chron Obstruct Pulmon Dis2014911145115425342899
- European Respiratory Society (ERS) [webpage on the Internet]European Lung White Book – Chapter 2: The Economic Burden of Lung Disease [updated 2016] Available from: http://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/Accessed October 12, 2016
- AdeloyeDChuaSLeeCGlobal and regional estimates of COPD prevalence: systematic review and meta-analysisJ Glob Health20155202041526755942
- StallbergBJansonCJohanssonGManagement, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)Prim Care Respir J2014231384524346825
- ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
- YohannesAMAlexopoulosGSDepression and anxiety in patients with COPDEur Respir Rev20142313334534925176970
- SarkarMBhardwajRMadabhaviIKhatanaJOsteoporosis in chronic obstructive pulmonary diseaseClin Med Insights Circ Respir Pulm Med2015952125788838
- PatelJGNagarSPDalalAAIndirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United StatesInt J Chron Obstruct Pulmon Dis20149128930024672234
- LofdahlCGTillingBEkstromTJorgensenLJohanssonGLarssonKCOPD health care in Sweden – a study in primary and secondary careRespir Med2010104340441119963361
- SundhJOsterlund EfraimssonEJansonCMontgomerySStallbergBLisspersKManagement of COPD exacerbations in primary care: a clinical cohort studyPrim Care Respir J201322439339924114334
- JanssonSABackmanHStenlingALindbergARonmarkELundbackBHealth economic costs of COPD in Sweden by disease severity – has it changed during a ten years period?Respir Med2013107121931193823910072
- ChapmanKRManninoDMSorianoJBEpidemiology and costs of chronic obstructive pulmonary diseaseEur Respir J200627118820716387952
- Statistics Sweden [webpage on the Internet]Longitudinal Integration Database for Health Insurance and Labour Market Studies [LISA by Swedish acronym 2004] Available from: https://www.scb.se/en_/Services/Guidance-for-researchers-and-universities/SCB-Data/Longitudinal-integration-database-for-health-insurance-and-labour-market-studies-LISA-by-Swedish-acronym/Accessed June 26, 2017
- Socialstyrelsen [homepage on the Internet] Available from: http://www.socialstyrelsen.se/registerAccessed June 26, 2017
- University of Manitoba – Community of Health Sciences – Manitoba Center for Health Policy [webpage on the Internet]Concept Description: Charlson Comorbidity Index [updated January 22, 2016] Available from: http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?conceptID=1098Accessed June 26, 2017
- FooJLandisSHMaskellJContinuing to confront COPD international patient survey: economic impact of COPD in 12 countriesPLoS One2016114e015261827092775
- LokkeAHilbergOTonnesenPIbsenRKjellbergJJennumPDirect and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998–2010BMJ Open201441e004069
- WackerMEJorresRASchulzHDirect and indirect costs of COPD and its comorbidities: results from the German COSYCONET studyRespir Med2016111394626725462
- MapelDWHurleyJSFrostFJPetersenHVPicchiMACoultasDBHealth care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organizationArch Intern Med2000160172653265810999980
- DarkowTChastekBJShahHPhillipsALHealth care costs among individuals with chronic obstructive pulmonary disease within several large, multi-state employersJ Occup Environ Med200850101130113818849758
- MillerJDFosterTBoulangerLDirect costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) dataCOPD20052331131817146996
- MenzinJBoulangerLMartonJThe economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare populationRespir Med200810291248125618620852
- JensenMBFenger-GronMFonagerKOmlandOVindingALHansenJGChronic obstructive pulmonary disease involves substantial health-care service and social benefit costsDan Med J2013601A455723340185
- NairKGhushchyanVVan Den BosJBurden of illness for an employed population with chronic obstructive pulmonary diseasePopul Health Manag201215526727522401150
- SharafkhanehAPetersenNJYuHJDalalAAJohnsonMLHananiaNABurden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs populationInt J Chron Obstruct Pulmon Dis2010512513220461144
- LinPJShayaFTScharfSMEconomic implications of comorbid conditions among Medicaid beneficiaries with COPDRespir Med2010104569770419954941
- HalpernMTStanfordRHBorkerRThe burden of COPD in the U.S.A.: results from the Confronting COPD SurveyRespir Med200397Suppl CS81S8912647946
- BildeLRud SvenningADollerupJBaekke BorgeskovHLangePThe cost of treating patients with COPD in Denmark – a population study of COPD patients compared with non-COPD controlsRespir Med2007101353954616889949
- HuberMBWackerMEVogelmeierCFLeidlRExcess costs of comorbidities in chronic obstructive pulmonary disease: a systematic reviewPLoS One2015104e012329225875204
- JanssonSABackmanHRonmarkELundbackBLindbergAHospitalization due to co-morbid conditions is the main cost driver among subjects with COPD – a report from the population-based OLIN COPD studyCOPD201512438138925415366
- SchwabPDhamaneADHopsonSDImpact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis20171273574428260880
- MennPHeinrichJHuberRMDirect medical costs of COPD – an excess cost approach based on two population-based studiesRespir Med2012106454054822100535
- Global Initiative for Chronic Obstructive Lung Disease (GOLD) [web-page on the Internet]Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [Updated 2016] Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Accessed February 5, 2016
- AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
- DhamaneADMoretzCZhouYCOPD exacerbation frequency and its association with health care resource utilization and costsInt J Chron Obstruct Pulmon Dis20151012609261826664109
- LisspersKJohanssonGJanssonCImprovement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS studyRespir Med201410891345135425002194
- HolgateSBisgaardHBjermerLThe Brussels Declaration: the need for change in asthma managementEur Respir J20083261433144219043008
- PinnockHThomasMTsiligianniIThe International Primary Care Respiratory Group (IPCRG) research needs statement 2010Prim Care Respir J201019Suppl 1S1S20